Citation | Barlind, JG; Bauer, UA; Birch, AM; Birtles, S; Buckett, LK; Butlin, RJ; Davies, RD; Eriksson, JW; Hammond, CD; Hovland, R; Johannesson, P; Johansson, MJ; Kemmitt, PD; Lindmark, BT; Morentin Gutierrez, P; Noeske, TA; Nordin, A; O'Donnell, CJ; Petersson, AU; Redzic, A; Turnbull, AV; Vinblad, J Design and optimization of pyrazinecarboxamide-based inhibitors of diacylglycerol acyltransferase 1 (DGAT1) leading to a clinical candidate dimethylpyrazinecarboxamide phenylcyclohexylacetic acid (AZD7687). J Med Chem55:10610-29 (2012) [PubMed] Article |
---|
SMILES | Cc1nc(C(F)F)c(nc1-c1ccc(cc1)[C@H]1CC[C@H](CC(O)=O)CC1)C(N)=O |r,wU:16.17,wD:19.21,(46.43,-53.65,;45.1,-52.89,;43.77,-53.66,;42.43,-52.89,;41.1,-53.66,;39.76,-52.89,;41.1,-55.2,;42.43,-51.35,;43.76,-50.58,;45.1,-51.35,;46.43,-50.58,;47.76,-51.35,;49.1,-50.58,;49.09,-49.03,;47.76,-48.27,;46.43,-49.04,;50.43,-48.26,;50.42,-46.72,;51.76,-45.95,;53.09,-46.72,;54.43,-45.95,;55.76,-46.72,;57.09,-45.95,;55.76,-48.26,;53.09,-48.26,;51.76,-49.03,;41.1,-50.57,;39.76,-51.34,;41.1,-49.03,)| |